Heparin for Moderately Ill Patients with Covid-19
Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle, Faris Alomran, Khalid Alayed, Mohammed Alsheef, Fahad AlSumait, Carlos Eduardo Pompilio, Catherine Sperlich, Sabrena Tangri, Terence Tang, Peter Jaksa, Deepa Suryanarayan, Mozah Almarshoodi, Lana Castellucci, Paula D. James, David Lillicrap, Marc Carrier, Andrew Beckett, Christos Colovos, Jai Jayakar, Marie-Pier Arsenault, Cynthia Wu, Karine Doyon, E. Roseann Andreou, Vera Dounaevskaia, Eric K. Tseng, Gloria Lim, Michael Fralick, Saskia Middeldorp, Agnes Y.Y. Lee, Fei Zuo, Bruno R. da Costa, Kevin E. Thorpe, Elnara Márcia Negri, Mary Cushman, Peter Jüni, the RAPID Trial investigators
medRxiv 2021.07.08.21259351; doi: https://doi.org/10.1101/2021.07.08.21259351
